Teva Pharmaceutical Industries Limited

OTCPK:TEVJ.F Stock Report

Market Cap: US$40.1b

Teva Pharmaceutical Industries Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:TEVJ.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 May 26SellUS$384,444Amir WeissIndividual10,679US$36.00
05 May 26SellUS$1,062,000Richard DaniellIndividual30,000US$35.40
01 May 26SellUS$5,045,118Mark SabagIndividual144,180US$34.99
30 Apr 26SellUS$750,620Christine FoxIndividual21,258US$35.31
17 Mar 26SellUS$1,871,816Mark SabagIndividual62,102US$30.14
16 Dec 25SellUS$371,504Amir WeissIndividual12,300US$30.20
09 Dec 25SellUS$2,817,677Mark SabagIndividual98,168US$28.70
14 Nov 25SellUS$753,321Christine FoxIndividual30,000US$25.11
06 Nov 25SellUS$300,564Amir WeissIndividual12,300US$24.44
05 Sep 25BuyUS$20,988David McavoyIndividual1,113US$18.86

Insider Trading Volume

Insider Buying: TEVJ.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TEVJ.F?
Owner TypeNumber of SharesOwnership Percentage
State or Government1,021,0860.0877%
Individual Insiders5,113,1350.439%
Sovereign Wealth Funds74,581,1856.4%
General Public276,893,67723.8%
Institutions806,817,88969.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 54.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.4%
Norges Bank Investment Management
74,581,185US$2.6b0%0.15%
5.85%
BlackRock, Inc.
68,138,212US$2.3b0%0.03%
5.34%
Phoenix Investments & Finances Ltd
62,160,528US$2.1b2.8%9.81%
4.01%
Harel Insurance Investments & Financial Services Ltd
46,723,543US$1.6b2.2%6.84%
3.51%
WCM Investment Management, LLC
40,820,600US$1.4b191%1.67%
3.4%
Migdal Mutual Funds Ltd.
39,640,253US$1.4b1.36%5.48%
3.4%
Menora Mivtachim Provident Funds
39,626,383US$1.4b0.79%3.54%
3.3%
Clal Financial Management Ltd
38,446,506US$1.3b2.79%5.85%
2.7%
Vanguard Capital Management, LLC
31,423,887US$1.1b0.5%0.02%
2.56%
FMR LLC
29,844,694US$1.0b15.1%0.04%
2.38%
Lingotto Investment Management LLP
27,770,857US$956.7m-2.29%1.73%
1.55%
State Street Global Advisors, Inc.
18,026,419US$621.0m-0.11%0.02%
1.31%
Rubric Capital Management LP
15,250,000US$525.4m-28.6%5.67%
1.03%
Altshuler Shaham Ltd.
11,980,097US$412.7m33%4.94%
1%
Capital Research and Management Company
11,656,840US$401.6m126%0.01%
0.91%
Geode Capital Management, LLC
10,589,798US$364.8m2.3%0.02%
0.87%
Vanguard Fiduciary Trust Company
10,114,776US$348.5m0.49%0.04%
0.66%
Wellington Management Group LLP
7,720,130US$266.0m6.46%0.04%
0.66%
Northern Trust Global Investments
7,706,942US$265.5m0%0.03%
0.65%
Australian Super Pty Ltd
7,564,458US$260.6m-3.63%0.19%
0.6%
Menora Mivtachim Insurance Ltd.
7,027,830US$242.1m0%19.17%
0.58%
Janus Henderson Group plc
6,772,130US$233.3m2.72%0.07%
0.57%
Glenview Capital Management, LLC
6,660,220US$229.4m-60.2%5.41%
0.56%
JPMorgan Chase & Co.
6,503,449US$224.0m532%0.03%
0.53%
Polar Capital Holdings Plc
6,197,698US$213.5m3.12%0.45%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 09:37
End of Day Share Price 2026/06/04 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Teva Pharmaceutical Industries Limited is covered by 45 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Balaji PrasadBarclays
Glen SantangeloBarclays